FDA panel split on approach to COVID-19 vaccines for younger children
Regulatory NewsMichael Mezher • Joanne S. Eglovitch
BiologicsBiotechnologyClinical TrialsFDA meeting and communication strategyNorth AmericaResearch, Design and DevelopmentRegulatory NewsMichael Mezher • Joanne S. EglovitchBiologicsBiotechnologyClinical TrialsFDA meeting and communication strategyNorth AmericaResearch, Design and Development